Canaccord Genuity Cuts Price Target on Meridian Bioscience (VIVO) Following In-Line Quarter Results
Tweet Send to a Friend
Canaccord Genuity reiterated a Hold rating on Meridian Biosciences (NASDAQ: VIVO), and cut the price target to $19.00 (from $20.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
